Discounted Cash Flow
Conmed Corp.
—
—
Average annual growth rates
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
Endpoint CAGR (better for long term trend)
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
Projected growth rate
—
—
%
%
Historical inputs (10 fiscal years)
| YEAR | Sales | Net Income | Free Cash Flow | Net Margin | EPS (diluted) |
|---|---|---|---|---|---|
| 2016 | $763.5m | $14.7m | $23.5m | 1.9% | $0.53 |
| 2017 | $796.4m (4.3%) | $55.5m (278.4%) | $52.7m (124.7%) | 7.0% (262.8%) | $1.99 (275.5%) |
| 2018 | $859.6m (7.9%) | $40.9m (-26.4%) | $58.2m (10.4%) | 4.8% (-31.8%) | $1.45 (-27.1%) |
| 2019 | $955.1m (11.1%) | $28.6m (-29.9%) | $75.1m (29.0%) | 3.0% (-36.9%) | $1.01 (-30.3%) |
| 2020 | $862.5m (-9.7%) | $9.5m (-66.7%) | $51.5m (-31.4%) | 1.1% (-63.2%) | $0.33 (-67.3%) |
| 2021 | $1.0b (17.2%) | $62.5m (557.2%) | $96.9m (88.1%) | 6.2% (460.8%) | $2.14 (548.5%) |
| 2022 | $1.0b (3.4%) | $-80.6m (-228.8%) | $11.6m (-88.1%) | -7.7% (-224.6%) | $-2.68 (-225.2%) |
| 2023 | $1.2b (19.1%) | $64.5m (180.0%) | $106.3m (818.1%) | 5.2% (167.2%) | $2.10 (178.4%) |
| 2024 | $1.3b (5.0%) | $132.4m (105.4%) | $153.9m (44.7%) | 10.1% (95.6%) | $4.29 (104.3%) |
| 2025 | $1.4b (5.2%) | $47.1m (-64.5%) | $150.9m (-2.0%) | 3.4% (-66.2%) | $1.52 (-64.6%) |
Base FCF: — (latest fiscal year)
Discount rate: % —
Terminal growth: —
Projection period: — years
Alt A decline yrs:
Alt B total yrs:
Projected cash flows
| Year | Projected cash flow | Discount Factor | Present Value |
|---|
PV of projected FCF: —
Terminal FCF: —
Terminal value: —
PV of terminal value: —
Enterprise value (DCF): —
Current price: —
—Alternative DCF Models
| Model | Fair Value | Upside | PV(FCFs) | PV(Terminal) | Total Years |
|---|---|---|---|---|---|
| Standard (10yr→TV) | — | — | — | — | 10 + TV |
| Alt A (Gradual Decline) | — | — | — | — | — |
| Alt B (30yr Hard Stop) | — | — | — | N/A | — |
This is a simplified DCF model for illustration. It uses reported free cash flow, a single growth assumption, fixed WACC, and a Gordon Growth terminal value. It is not investment advice.